What is Scribenote?
Scribenote operates at the intersection of veterinary medicine and advanced software engineering. Founded by a multidisciplinary team of veterinarians and engineers, the company provides an automated solution for generating SOAP notes, effectively streamlining the documentation process. By replacing manual typing with intelligent automation, Scribenote addresses the systemic issue of burnout in the veterinary profession, allowing clinicians to reclaim their time and improve their work-life balance. The platform is designed to integrate seamlessly into existing clinical workflows, positioning the company as a vital infrastructure player in the modern veterinary practice management ecosystem.
How much funding has Scribenote raised?
Scribenote has raised a total of $8.2M across 1 funding round:
Angel/Seed
$8.2M
Angel/Seed (2024): $8.2M with participation from Andreessen Horowitz
Key Investors in Scribenote
Andreessen Horowitz
Founded in 2009, Andreessen Horowitz is a prominent American venture capital firm that provides strategic backing to both early-stage startups and established growth-stage enterprises across the technology sector.
What's next for Scribenote?
Looking ahead, the strategic deployment of this capital will likely focus on product expansion and market penetration. As the company transitions from its initial development phase into a broader scaling strategy, the focus will shift toward enhancing the accuracy and versatility of its automated note-taking capabilities. Furthermore, the firm is expected to invest in talent acquisition and infrastructure to support a growing user base. By maintaining its commitment to clinical efficiency, Scribenote is well-positioned to capture a significant share of the veterinary health technology market, setting a new standard for how medical records are managed in high-pressure clinical environments.
See full Scribenote company page
